Nvidia (NASDAQ:NVDA) insiders have sold more than $1 billion worth of company stock over the past year, according to a report by the Financial Times. The surge in executive stock sales comes as Nvidia’s share price has skyrocketed, driven by investor enthusiasm around artificial intelligence.
Over $500 million of those sales occurred in June alone, coinciding with Nvidia reaching a record-high valuation. SEC filings reveal that CEO Jensen Huang began offloading shares this week for the first time since September, signaling growing insider activity.
On Wednesday, Nvidia's stock hit an all-time high, briefly making it the world’s most valuable publicly traded company. The rally followed an analyst’s note predicting Nvidia would benefit from a “Golden Wave” of AI demand, reinforcing Wall Street’s bullish stance on the sector.
The stock’s performance reflects renewed market momentum for AI-related equities. Investors have returned to high-growth technology names, particularly those tied to chipmaking and generative AI, which have led major market gains since 2023.
Despite recent geopolitical and trade uncertainties, Nvidia shares have rebounded more than 60% from their April 4 closing low, when the market was rattled by President Trump’s global tariff policy. Optimism over potential trade resolutions and continued AI tailwinds have boosted sentiment around the California-based semiconductor giant.
Nvidia did not respond to Reuters’ request for comment on the insider sales.
As AI adoption accelerates, Nvidia remains at the center of the market narrative, but the spike in executive selling may raise questions for long-term investors. Still, the company’s dominance in GPU and AI chip markets continues to fuel its remarkable valuation run.


Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom 



